Case number 1:21-cv-01102
Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 21, 2023 | 43 | NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Response to Defendants' Second Set of Common Interrogatories (No. 3) and (2) Plaintiffs' Supplemental Response to Defendants' First Set of Interrogatories (No. 1) filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 03/21/2023) (3) |
| Feb 22, 2023 | 42 | MOTION for Pro Hac Vice Appearance of Attorney Candace Walther - filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification for Candace Walther)(Silver, Daniel) (Entered: 02/22/2023) (Certification for Candace Walther) (1) |
| Feb 22, 2023 | 42 | MOTION for Pro Hac Vice Appearance of Attorney Candace Walther - filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification for Candace Walther)(Silver, Daniel) (Entered: 02/22/2023) (Main Document) (2) |
| Feb 2, 2023 | 41 | NOTICE OF SERVICE of Plaintiffs' Supplemental Response to Defendants Third Set of Common Interrogatories (No. 4) filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 02/02/2023) (3) |
| Oct 26, 2022 | 40 | NOTICE OF SERVICE of (1) Plaintiffs' Amended Infringement Contentions directed to MSN related to ANDA No. 215975 and (2) Plaintiffs' Amended Infringement Contentions directed to MSN related to ANDA No. 215976 filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 10/26/2022) (3) |
| Sep 28, 2022 | 39 | PROPOSED ORDER Amended Stipulated Protective Order by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 09/28/2022) (30) |
| Sep 2, 2022 | 38 | NOTICE OF SERVICE of Plaintiffs' First Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery of ESI filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 09/02/2022) (4) |
| Jul 27, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| Jul 15, 2022 | 37 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses Defendants Second Set of Common Interrogatories (No. 3) filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd..(Joyce, Alexandra) |
| Jun 30, 2022 | 36 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Response to Fresenius Kabi USA's Invalidity Contentions and (2) Plaintiffs' Response to MSN's Invalidity Contentions filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| May 16, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 36 has been deleted from the docket. This matter is consolidated with C.A. No. 21-870 and all filings should be made in the lead case only. (dlw) |
| May 9, 2022 | 35 | Proposed Order (16) Docket Text: PROPOSED ORDER // Scheduling Order by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 5/10/2022 (dlw). |
| Apr 29, 2022 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Common Requests for Production of Documents and Things to Defendants (Nos. 1-30) and (2) Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-6) filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Apr 28, 2022 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Common Requests for Production of Documents and Things (Nos. 1-105) and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-2) filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Apr 7, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS (ntl) |
| Apr 7, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:21-cv-00870-LPS. ALL PAPERS SHALL BE FILED IN LEAD CASE NO. 21-870-LPS (SEE D.I. 23) (ntl) |
| Apr 1, 2022 | 32 | Letter (2) Docket Text: Letter to The Honorable P. Stark from Daniel M. Silver regarding Joint Status Report regarding Court's March 29, 2022 Oral Order. (Silver, Daniel) |
| Mar 29, 2022 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants First Set of Common Interrogatories to Plaintiffs (Nos. 1 2); and 2) Defendants First Set of Common Requests for Production of Documents and Things to Plaintiffs (Nos. 1 104) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Fresenius Kabi AG, Fresenius Kabi USA, LLC.(Pascale, Karen) |
| Mar 29, 2022 | N/A | Order (0) Docket Text: ORAL ORDER: The Court observes that this case is marked as related to one or more other cases now pending before another judge of this Court. Accordingly, IT IS HEREBY ORDERED that the parties shall meet and confer and, no later than April 1, submit a joint status report, providing their position(s) as to which judge this case should be reassigned to. ORDERED by Judge Leonard P. Stark on 3/29/22. (ntl) |
| Mar 29, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Leonard P. Stark of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS (ntl) |
| Mar 23, 2022 | 29 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Andrew E. Renison as co-counsel.. (Joyce, Alexandra) |
| Mar 22, 2022 | 28 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Gary A. Coad as co-counsel. Reason for request: no longer associated with ArentFox Schiff LLP. (Pascale, Karen) |
| Mar 22, 2022 | 27 | Notice (Other) (3) Docket Text: NOTICE of Change of Firm Name and E-Mail Addresses of Pro Hac Vice Counsel by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Fresenius Kabi AG, Fresenius Kabi USA, LLC (Pascale, Karen) |
| Mar 1, 2022 | 26 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Novartis's Initial Infringement Contentions Directed to Defendants filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Feb 8, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (25 in 1:21-cv-01102-LPS, 28 in 1:21-cv-00870-LPS, 27 in 1:21-cv-00981-LPS) Stipulated Protective Order. Signed by Judge Leonard P. Stark on 2/8/22. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS (ntl) |
| Feb 4, 2022 | 25 | Proposed Order (30) Docket Text: PROPOSED ORDER Stipulated Protective Order by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Feb 1, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 2/1/2022. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS(dlb) |
| Feb 1, 2022 | 23 | Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 3/31/2023. Status Report due by 6/30/2023. Joint Claim Construction Brief due by 10/11/2022. A Markman Hearing is set for 11/7/2022 at 10:00 AM before Judge Leonard P. Stark. Proposed Pretrial Order due by 1/9/2024. A Final Pretrial Conference is set for 1/23/2024 at 10:00 AM before Judge Leonard P. Stark. A 7-day Bench Trial is set for 2/5/2024 at 08:30 AM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 1/31/22. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS (ntl) |
| Feb 1, 2022 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Jan 31, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (22 in 1:21-cv-01102-LPS, 24 in 1:21-cv-00981-LPS, 25 in 1:21-cv-00870-LPS) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 4, 2022 filed by MSN Laboratories Pvt. Ltd., Fresenius Kabi USA, LLC, Fresenius Kabi AG, MSN Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/31/22. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS (ntl) |
| Jan 28, 2022 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 4, 2022 - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Fresenius Kabi AG, Fresenius Kabi USA, LLC. (Pascale, Karen) |
| Jan 18, 2022 | 21 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Rule 26(a)(1)(A) Disclosures and (2) Plaintiff's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery of ESI filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jan 18, 2022 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and 2) Defendant MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.'s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Pascale, Karen) |
| Dec 21, 2021 | 19 | Notice (Other) (2) Docket Text: NOTICE of withdraw of appearance of Barbara R. Rudolph by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation (Joyce, Alexandra) |
| Dec 14, 2021 | 18 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Discovery In Patent Litigation Pursuant to Paragraph 4(A) of the Default Standard for Discovery and (2) File Histories filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Dec 10, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gary A. Coad for MSN Laboratories Pvt. Ltd., for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Dec 9, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Brian H. Gold and Bradford C. Frese for MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Dec 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Gary A. Coad, and Brian H. Gold filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 12/8/21. (ntl) |
| Dec 3, 2021 | 17 | Joint Letter Regarding Disputed Scheduling Order Provisions (1) |
| Dec 3, 2021 | 17 | Main Document (20) Docket Text: PROPOSED ORDER re: Case Scheduling by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Attachments: # (1) Joint Letter Regarding Disputed Scheduling Order Provisions)(Silver, Daniel) |
| Dec 3, 2021 | 16 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Gary A. Coad, and Brian H. Gold - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Pascale, Karen) |
| Nov 30, 2021 | 15 | Stipulation (2) Docket Text: STIPULATION Extending Deadline to File Sheduling Order by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Nov 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:21-cv-01102-LPS, 17 in 1:21-cv-00981-LPS, 18 in 1:21-cv-00870-LPS) STIPULATION Extending Deadline to File Scheduling Order filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd. Signed by Judge Leonard P. Stark on 11/30/21. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS (ntl) |
| Nov 16, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than November 30, 2021. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 11/16/21. Associated Cases: 1:21-cv-00870-LPS, 1:21-cv-00981-LPS, 1:21-cv-01102-LPS (ntl) |
| Oct 4, 2021 | 13 | Answer to Counterclaim (18) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Sep 13, 2021 | 12 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Pascale, Karen) |
| Sep 13, 2021 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Pascale, Karen) |
| Aug 12, 2021 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Defendants' Deadline to Answer, Move or Otherwise Respond to the Complaint to Septemebr 13, 2021 - filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Aug 12, 2021 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd.: For MSN Laboratories Pvt. Ltd. waiver sent on 8/11/2021, answer due 10/12/2021. (Silver, Daniel) |
| Aug 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME Defendants' Deadline to Answer, Move or Otherwise Respond to the Complaint to Septemebr 13, 2021 filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd. Signed by Judge Leonard P. Stark on 8/12/21. (ntl) |
| Aug 4, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Jul 30, 2021 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd.. MSN Pharmaceuticals Inc. served on 7/30/2021, answer due 8/20/2021. (Joyce, Alexandra) |
| Jul 29, 2021 | 7 | Summons Issued (2) |
| Jul 29, 2021 | 7 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Pvt. Ltd. on 7/29/2021; MSN Pharmaceuticals Inc. on 7/29/2021. (Attachments: # (1) Summons Issued)(myr) |
| Jul 29, 2021 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka America, Inc., Corporate Parent Otsuka Pharmaceutical Co., Ltd., Corporate Parent Otsuka Holdings Co., Ltd. for Astex Therapeutics Ltd. filed by Astex Therapeutics Ltd.. (myr) |
| Jul 29, 2021 | 1 | Complaint* (1) |
| Jul 29, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (myr) |
| Jul 29, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,324,225 ;8,415,355 ;8,685,980 ;8,962,630 ;9,416,136. (myr) |
| Jul 29, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 18, 2021. Date of Expiration of Patent: See Attached. (myr) |
| Jul 29, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Jul 29, 2021 | 1 | Civil Cover Sheet (2) |
| Jul 29, 2021 | 1 | Exhibit A-E (435) |
| Jul 29, 2021 | 1 | Main Document (37) Docket Text: COMPLAINT filed against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3668076.) - filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(myr) |
